🔥 Premium AI-powered Stock Picks from InvestingPro Now up to 50% OffCLAIM SALE

PRESS DIGEST - Wall Street Journal - Feb 29

Published 2016-02-29, 12:42 a/m
© Reuters.  PRESS DIGEST - Wall Street Journal - Feb 29
MSFT
-
PSON
-
BHC
-

Feb 29 (Reuters) - The following are the top stories in the
Wall Street Journal. Reuters has not verified these stories and
does not vouch for their accuracy.

- Valeant Pharmaceuticals International Inc (N:VRX) VRX.TO said
Michael Pearson (L:PSON) has returned from medical leave to lead the
company as chief executive officer, with the role of chairman
split off.

- "Spotlight", the film on the Boston Globe's investigative
team, won the Academy Award for best picture, while "The
Revenant" walked away with best director for Alejandro Inarritu
and best actor for Leonardo DiCaprio.

- Helicopter manufacturers and operators from around the
globe will gather this week to revamp safety initiatives after
years of lackluster results marked by stubbornly high fatality
rates.

- Microsoft Corp 's MSFT.O new Cyber Defense Operations
Center is at the heart of the software giant's campaign to
rebuild its reputation for security at a time when the number of
potential cyberattack targets has exploded.

- The U.S. market is so oversupplied with oil that traders
are experimenting with a new place for storing excess crude -
Railcars.

- The Federal Communications Commission is probing whether
big cable firms use special contract provisions to discourage
media companies - from Walt Disney Co DIS.N to smaller firms -
from running programming on the Internet.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.